Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Bioinformatics (Oxford, England)
|
February 15, 2026
AutoFlow: An interactive Shiny app for supervised and unsupervised flow cytometry analysis
Freya E R Woods, Emilyanne Leonard, Timothy Ebbels, et al.
Frontiers in Pharmacology
|
April 17, 2023
Optimal experimental design for efficient toxicity testing in microphysiological systems: A bone marrow application
Jonathan Cairns, Emilyanne Leonard, Kainat Khan, et al.
Nanoscale
|
March 28, 2019
Extracellular vesicles induce minimal hepatotoxicity and immunogenicity
Amer F Saleh, Elisa Lázaro-Ibáñez, Malin A-M Forsgard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2022
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper
Giuditta Illuzzi, Anna D Staniszewska, Sonja J Gill, et al.
Nature Communications
|
March 25, 2026
A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader
Monica C Rodrigo-Brenni, Jasper C Komen, Ghaith M Hamza, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Bioinformatics (Oxford, England)
|
February 15, 2026
AutoFlow: An interactive Shiny app for supervised and unsupervised flow cytometry analysis
Freya E R Woods, Emilyanne Leonard, Timothy Ebbels, et al.
Frontiers in Pharmacology
|
April 17, 2023
Optimal experimental design for efficient toxicity testing in microphysiological systems: A bone marrow application
Jonathan Cairns, Emilyanne Leonard, Kainat Khan, et al.
Nanoscale
|
March 28, 2019
Extracellular vesicles induce minimal hepatotoxicity and immunogenicity
Amer F Saleh, Elisa Lázaro-Ibáñez, Malin A-M Forsgard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2022
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper
Giuditta Illuzzi, Anna D Staniszewska, Sonja J Gill, et al.
Nature Communications
|
March 25, 2026
A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader
Monica C Rodrigo-Brenni, Jasper C Komen, Ghaith M Hamza, et al.
Page
of 1